OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The flavonoid fisetin ameliorates renal fibrosis by inhibiting SMAD3 phosphorylation, oxidative damage, and inflammation in ureteral obstructed kidney in mice
Ha Young Ju, Jongwan Kim, Sang Jun Han
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 3, pp. 325-339
Open Access | Times Cited: 16

Showing 16 citing articles:

Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics
Mohammad Islamuddin, Xuebin Qin
Cell Death Discovery (2024) Vol. 10, Iss. 1
Open Access | Times Cited: 18

Hederagenin improves renal fibrosis in diabetic nephropathy by regulating Smad3/NOX4/SLC7A11 signaling-mediated tubular cell ferroptosis
Jian Jia, Ruizhi Tan, Linghui Xu, et al.
International Immunopharmacology (2024) Vol. 135, pp. 112303-112303
Closed Access | Times Cited: 9

Effects of Fisetin Treatment on Cellular Senescence of Various Tissues and Organs of Old Sheep
Charles Huard, Xueqin Gao, Maria E. Dey Hazra, et al.
Antioxidants (2023) Vol. 12, Iss. 8, pp. 1646-1646
Open Access | Times Cited: 14

Macrophage polarization in tissue fibrosis
Huidan Yang, Hao Cheng, Rongrong Dai, et al.
PeerJ (2023) Vol. 11, pp. e16092-e16092
Open Access | Times Cited: 14

Fisetin as a senotherapeutic agent: Evidence and perspectives for age-related diseases
Juliette Tavenier, Jan O. Nehlin, Morten Baltzer Houlind, et al.
Mechanisms of Ageing and Development (2024) Vol. 222, pp. 111995-111995
Open Access | Times Cited: 4

Post-translational modifications of collagen and its related diseases in metabolic pathways
Linghong Guo, Xiang Wang, Zhaoping Pan, et al.
Acta Pharmaceutica Sinica B (2025)
Open Access

Pathogenesis and management of renal fibrosis induced by unilateral ureteral obstruction
Qi Yan Nan, Shang Guo Piao, Ji Zhe Jin, et al.
Kidney Research and Clinical Practice (2024) Vol. 43, Iss. 5, pp. 586-599
Open Access | Times Cited: 3

Targeting senescence to prevent diabetic kidney disease: Exploring molecular mechanisms and potential therapeutic targets for disease management
Paige Charlotte Alison Phillips, Mafalda de Sousa Loreto Aresta Branco, Chelsy L. Cliff, et al.
Diabetic Medicine (2024)
Open Access | Times Cited: 3

The protective effects of fisetin in metabolic disorders: a focus on oxidative stress and associated events
Mahboobe Sattari, Jamal Amri, Mohammad Esmaeil Shahaboddin, et al.
Journal of Diabetes & Metabolic Disorders (2024) Vol. 23, Iss. 2, pp. 1753-1771
Closed Access | Times Cited: 2

The Flavonoid Fisetin Reduces Multiple Physiological Risk Factors for Dementia
Pamela Maher
Neurochemistry International (2024) Vol. 178, pp. 105805-105805
Closed Access | Times Cited: 1

Association between dietary intake of flavonoid and chronic kidney disease in US adults: Evidence from NHANES 2007-2008, 2009-2010, and 2017-2018
Peijia Liu, Wujian Peng, Feng Hu, et al.
PLoS ONE (2024) Vol. 19, Iss. 8, pp. e0309026-e0309026
Open Access | Times Cited: 1

An Insight into Fisetin, The Miraculous Multifaceted Flavonol: Paving the Road for Enhanced Delivery Through Promising Pharmaceutical Nano-Formulations.
Asmaa H. Elwan, Soha M. El-Masry, Doaa A. Habib, et al.
Journal of Drug Delivery Science and Technology (2024), pp. 106292-106292
Closed Access | Times Cited: 1

A novel strategy employing the flavonoid fisetin to halt the progression of renal fibrosis in obstructive nephropathy
Tae‐Hwan Kwon
Kidney Research and Clinical Practice (2023) Vol. 42, Iss. 3, pp. 282-285
Open Access | Times Cited: 2

A therapeutic approach to identify leading molecules from natural products and therapeutic targets in CKD by network pharmacology
Yugant Krishnakumar Talati, Anil Bhanudas Gaikwad
PharmaNutrition (2024), pp. 100421-100421
Closed Access

Fisetin Treats Kidney Oxidative Stress, Inflammation, and Apoptosis in Rat Diarrhea
Khaled M. M. Koriem, Yousra K. O. Farouk
Frontiers in Bioscience-Scholar (2023) Vol. 15, Iss. 4
Open Access

Page 1

Scroll to top